These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38754417)

  • 1. Gut microbial β-glucuronidases influence endobiotic homeostasis and are modulated by diverse therapeutics.
    Simpson JB; Walker ME; Sekela JJ; Ivey SM; Jariwala PB; Storch CM; Kowalewski ME; Graboski AL; Lietzan AD; Walton WG; Davis KA; Cloer EW; Borlandelli V; Hsiao YC; Roberts LR; Perlman DH; Liang X; Overkleeft HS; Bhatt AP; Lu K; Redinbo MR
    Cell Host Microbe; 2024 Jun; 32(6):925-944.e10. PubMed ID: 38754417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbial β-glucuronidases reactivate estrogens as components of the estrobolome that reactivate estrogens.
    Ervin SM; Li H; Lim L; Roberts LR; Liang X; Mani S; Redinbo MR
    J Biol Chem; 2019 Dec; 294(49):18586-18599. PubMed ID: 31636122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, function, and inhibition of drug reactivating human gut microbial β-glucuronidases.
    Biernat KA; Pellock SJ; Bhatt AP; Bivins MM; Walton WG; Tran BNT; Wei L; Snider MC; Cesmat AP; Tripathy A; Erie DA; Redinbo MR
    Sci Rep; 2019 Jan; 9(1):825. PubMed ID: 30696850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of host and environmental factors on β-glucuronidase enzymatic activity: implications for gastrointestinal serotonin.
    Walsh J; Olavarria-Ramirez L; Lach G; Boehme M; Dinan TG; Cryan JF; Griffin BT; Hyland NP; Clarke G
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G816-G826. PubMed ID: 32146834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovering the Microbial Enzymes Driving Drug Toxicity with Activity-Based Protein Profiling.
    Jariwala PB; Pellock SJ; Goldfarb D; Cloer EW; Artola M; Simpson JB; Bhatt AP; Walton WG; Roberts LR; Major MB; Davies GJ; Overkleeft HS; Redinbo MR
    ACS Chem Biol; 2020 Jan; 15(1):217-225. PubMed ID: 31774274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting Regorafenib-Induced Toxicity through Inhibition of Gut Microbial β-Glucuronidases.
    Ervin SM; Hanley RP; Lim L; Walton WG; Pearce KH; Bhatt AP; James LI; Redinbo MR
    ACS Chem Biol; 2019 Dec; 14(12):2737-2744. PubMed ID: 31663730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metagenomics combined with activity-based proteomics point to gut bacterial enzymes that reactivate mycophenolate.
    Simpson JB; Sekela JJ; Graboski AL; Borlandelli VB; Bivins MM; Barker NK; Sorgen AA; Mordant AL; Johnson RL; Bhatt AP; Fodor AA; Herring LE; Overkleeft H; Lee JR; Redinbo MR
    Gut Microbes; 2022; 14(1):2107289. PubMed ID: 35953888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucuronides in the gut: Sugar-driven symbioses between microbe and host.
    Pellock SJ; Redinbo MR
    J Biol Chem; 2017 May; 292(21):8569-8576. PubMed ID: 28389557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and Characterization of FMN-Binding β-Glucuronidases in the Human Gut Microbiome.
    Pellock SJ; Walton WG; Ervin SM; Torres-Rivera D; Creekmore BC; Bergan G; Dunn ZD; Li B; Tripathy A; Redinbo MR
    J Mol Biol; 2019 Mar; 431(5):970-980. PubMed ID: 30658055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural Insights into Endobiotic Reactivation by Human Gut Microbiome-Encoded Sulfatases.
    Ervin SM; Simpson JB; Gibbs ME; Creekmore BC; Lim L; Walton WG; Gharaibeh RZ; Redinbo MR
    Biochemistry; 2020 Oct; 59(40):3939-3950. PubMed ID: 32993284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbial β-Glucuronidase: A key regulator of endobiotic homeostasis.
    Ning L; Hong J
    Cell Host Microbe; 2024 Jun; 32(6):783-785. PubMed ID: 38870895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Atlas of β-Glucuronidases in the Human Intestinal Microbiome.
    Pollet RM; D'Agostino EH; Walton WG; Xu Y; Little MS; Biernat KA; Pellock SJ; Patterson LM; Creekmore BC; Isenberg HN; Bahethi RR; Bhatt AP; Liu J; Gharaibeh RZ; Redinbo MR
    Structure; 2017 Jul; 25(7):967-977.e5. PubMed ID: 28578872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbial beta-glucuronidase and glycerol/diol dehydratase activity contribute to dietary heterocyclic amine biotransformation.
    Zhang J; Lacroix C; Wortmann E; Ruscheweyh HJ; Sunagawa S; Sturla SJ; Schwab C
    BMC Microbiol; 2019 May; 19(1):99. PubMed ID: 31096909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae.
    Little MS; Pellock SJ; Walton WG; Tripathy A; Redinbo MR
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E152-E161. PubMed ID: 29269393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse Gut Microbiome-Encoded β-Glucuronidases Identified Using Metagenome Analysis Guided by Protein Structure.
    Creekmore BC; Gray JH; Walton WG; Biernat KA; Little MS; Xu Y; Liu J; Gharaibeh RZ; Redinbo MR
    mSystems; 2019 Aug; 4(4):. PubMed ID: 31455640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and molecular determinants of a highly selective and efficient glycyrrhizin-hydrolyzing β-glucuronidase from Staphylococcus pasteuri 3I10.
    Wei B; Wang PP; Yan ZX; Yan R
    Appl Microbiol Biotechnol; 2018 Nov; 102(21):9193-9205. PubMed ID: 30109395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy.
    Bhatt AP; Pellock SJ; Biernat KA; Walton WG; Wallace BD; Creekmore BC; Letertre MM; Swann JR; Wilson ID; Roques JR; Darr DB; Bailey ST; Montgomery SA; Roach JM; Azcarate-Peril MA; Sartor RB; Gharaibeh RZ; Bultman SJ; Redinbo MR
    Proc Natl Acad Sci U S A; 2020 Mar; 117(13):7374-7381. PubMed ID: 32170007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active site flexibility revealed in crystal structures of Parabacteroides merdae β-glucuronidase from the human gut microbiome.
    Little MS; Ervin SM; Walton WG; Tripathy A; Xu Y; Liu J; Redinbo MR
    Protein Sci; 2018 Dec; 27(12):2010-2022. PubMed ID: 30230652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Administration of Conjugated Estrogen and Bazedoxifene Decreased Murine Fecal β-Glucuronidase Activity Without Impacting Overall Microbiome Community.
    Chen KLA; Liu X; Zhao YC; Hieronymi K; Rossi G; Auvil LS; Welge M; Bushell C; Smith RL; Carlson KE; Kim SH; Katzenellenbogen JA; Miller MJ; Madak-Erdogan Z
    Sci Rep; 2018 May; 8(1):8166. PubMed ID: 29802368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting drug-metagenome interactions: Variation in the microbial β-glucuronidase level in the human gut metagenomes.
    Elmassry MM; Kim S; Busby B
    PLoS One; 2021; 16(1):e0244876. PubMed ID: 33411719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.